Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Vaccines against an oncogenic isoform of HER2 (ErbB2) and methods of using the same

Vaccines against an oncogenic isoform of HER2 (ErbB2) and methods of using the same

US Patent 10842857 · Granted Nov 24, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Vaccines against an oncogenic isoform of HER2 (ErbB2) and methods of using the s2024
Vaccines against an oncogenic isoform of HER2 (ErbB2) and methods of using the s2024
Vaccines against an oncogenic isoform of HER2 (ErbB2) and methods of using the s2024
X-ray psoralen activated cancer therapy (X-PACT)2024
Niclosamide analogues and therapeutic use thereof2024
X-ray psoralen activated cancer therapy (X-PACT)2022
Cancer vaccines and methods of delivery2022
Cancer vaccines and methods of delivery2022
Cancer vaccines and methods of delivery2022
Vaccines against antigens involved in therapy resistance and methods of using sa2022
Vaccines against antigens involved in therapy resistance and methods of using sa2022
Vaccines against antigens involved in therapy resistance and methods of using sa2022